This Edition
ARTICLE | Clinical News
SNX-5422: Phase I started
WIR Staff
December 10, 2007 8:00 AM UTC
Serenex began a dose-escalation, U.S. Phase I trial of oral SNX-5422 in up to 50 patients. ...